Newsletters

ICER Update 10.04.22

 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER released a Final Evidence Report assessing the comparative clinical effectiveness and value

Read More »

ICER Update 01.27.22

Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. ICER has published its latest report on Unsupported Price Increases (UPI) of prescription

Read More »

ICER Update 01.22.21

Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has published its latest report on

Read More »

ICER Update 10.30.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has posted a Draft Scoping

Read More »

ICER Update 10.19.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a Final Evidence Report

Read More »

ICER Update 10.05.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a Final Evidence Report

Read More »

ICER Update 02.27.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update.Here is this week’s ICER recap: ICER released a Draft Evidence Report for

Read More »

ICER Update 04.27.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER unexpectedly released an Evidence Report

Read More »

ICER Update 03.23.20

NOTE: Since today’s update was written, ICER has announced either the indefinite postponement (Sickle Cell Disease, Cystic Fibrosis) or 2 to 3 month delay (NASH,

Read More »

ICER Update 01.29.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a draft evidence report

Read More »